Speaker:

David L. DeMets, PhD  “Max Halperin” Professor of Biostatistics, Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin

Objectives: 

• Recognize the remarkable decrease in cardiovascular risk over four decades
• Recognize the decrease in part due to a series of pharmacologic and device advance
• Identify the risks of reliance on biomarker or intermediate outcomes as surrogate outcomes

Locations:    

• Mayo Clinic Building, Taylor Auditorium
• Mayo Clinic Hospital, MCH Waugh Auditorium Side A (MCH 1-220A)
• Mayo Clinic Women’s Health Internal Medicine
• Mayo Clinic Family Medicine – Arrowhead
• Kingman Regional Medical Center
• Yuma Regional Medical Center
• Canyon Ranch Medical Center
• Mayo Clinic Primary Care – San Tan

ALL PHYSICIANS AND ALLIED STAFF ARE WELCOME

**NEW** ATTENDANCE REQUIREMENT 
A unique presentation code must be sent via text to 507-200-3010 
to record attendance and to ensure you receive CME credit for your attendance.  
NOTE:  Attendees must be present to receive code.

FACULTY DISCLOSURE

As a provider accredited by Accreditation Council on Continuing Medical Education (ACCME), Mayo Clinic College of Medicine, must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships is included course materials so participants may formulate their own judgments regarding the presentation.